Will EHR-enabled AI size up doctors for data-demanding patients?

The COVID-19 crisis has worsened or exposed myriad problems in healthcare delivery. One is the way patients find physicians and hospitals. AI can help with that.

So say two executives with healthcare AI startup Health at Scale in San Jose, California. Mohammed Saeed, MD, PhD, and Zahoor Elahi, make their case in Quartz.

After running through the deficiencies in popular doctor-shopping options like online reviews (one person’s opinion is just that) and national rankings by informed media (subjective perceptions color objective findings), the authors highlight a sleeping giant ready to rise and (data) mine: under-tapped Big Data in far-flung EHRs.

The problem there is enormity and complexity. Which is where AI could come in.

“We’re on the threshold of a new age, with artificial intelligence able to comb vast quantities of longitudinal patient data to spot patterns, make comparisons and predict outcomes in ways that can dramatically improve provider selection and patient care,” Saeed and Elahi write.

During the pandemic, AI-based provider selection could be “far more scalable and flexible,” given COVID-19 constraints and future patient backlogs, they propose.

“New approaches can also be distributed over a larger catchment or allow for selecting providers from coast to coast through greater telehealth options. On top of this, AI systems and machine learning can spot where normal referral patterns might be broken to step in and recommend a better option.”

To read it all, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

"The number of non-facility services reimbursed at less than direct costs grew 50% since 2024. The number of services under the MPFS for which reimbursement does not even cover cost likely is much higher than 300 services," the proposed AMA resolution states.

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.